​Radient Technologies Inc. (RTI) Releases Q3 2018 Results

Spotlight Companies |

Radient Technologies Inc. (TSX Venture:RTI) announced today that it has released its third quarter financial results for the fiscal year ended March 31, 2018. The reviewed financial statements, Management's Discussion and Analysis, and the CEO & CFO certifications for the period ended December 31, 2017 are available on www.SEDAR.com.

Key Highlights for Q3 2018

  • The Company finalized a Master Services Agreement (“MSA”) with Aurora Cannabis Inc. (“Aurora”) (TSX:ACB) (OTCQX:ACBFF) (Frankfurt:21P) (WKN:A1C4WM) related to the supply of standardized cannabis extracts for Aurora using its proprietary MAPTM technology. The agreement has an initial term of five years, with an option for Aurora to renew the agreement for an additional five years. The agreement will cover services delivered in Canada, Australia, and the European Union with Aurora having the right to negotiate with the Company to expand the jurisdictions covered. The MSA includes an Investor Rights Agreement that provides Aurora with certain rights to participate in future offerings, providing Aurora with the option to expand its ownership in the Company up to 19.99%.
  • Aurora completed a private placement of 4,541,889 units for total proceeds of $6.2 million, with each unit consisting of one common share of Radient and one common share purchase warrant. Units were priced at $1.37. Each warrant gives Aurora the right to purchase one common share of Radient for $1.71 for a period of 24 months.
  • Terry Booth, Founder and CEO of Aurora Cannabis Inc. was appointed to the Company’s Board of Directors.
  • The Company announced the signing of a Master Services Agreement with Terra Life Sciences group (“TLS”) pursuant to which the Company has agreed to perform certain services for TLS using its proprietary MAPTM technology, in relation to supply of standardized cannabis extracts. The agreement has an initial term of five years, with an option for TLS to renew the agreement for an additional five years.
  • The Company completed the previously announced conversion of $6,210,633 of debt (inclusive of interest) with AVAC Ltd. (“AVAC”), an arm’s length third party creditor, for 9,424,330 common shares at a price of $0.66 per share. The conversion is a significant transaction in the Company’s plans to continue strengthening its balance sheet.
  • Health Canada released their “Proposed Approach to the Regulation of Cannabis” (the “Proposals”) publication. The Company is pleased with the progressive nature of the Proposals and that Radient’s business model would be a consistent fit within a healthy, inclusive market for cannabis products under the Proposals.
  • 1,754,815 common shares related to stock option exercises were issued for proceeds of $1,163,548 and 39,362,962 common shares related to warrant exercises were issued for proceeds of $12,718,099.
  • 933,333 units of the Company were issued related to finders’ options exercises for total proceeds of $420,000 at an exercise price of $0.45. These units included issuance of 933,333 common shares and 466,667 common share purchase warrants entitling the holder to subscribe for additional common shares at a price of $0.70 per common share until March 9, 2019.
  • As of December 31, 2017, the cash position was strong at $24.4 million.

Post Reporting Events



  • Health Canada notified the Company that its Licensed Dealer application pursuant to the provisions of the Controlled Drugs and Substances Act had been approved. The licence allows the Company to conduct research and develop products related to cannabis at its Edmonton research and development facility.
  • The Company announced the signing of a Master Services Agreement with Bonify pursuant to which the Company has agreed to perform certain services for Bonify using its proprietary MAPTM technology, in relation to supply a variety of cannabis extracts. The agreement has an initial term of five years, with an option for Bonify to renew the agreement for an additional five years.
  • The Company was named to the 2018 TSX Venture 50 list of companies. The Venture 50 are the top ten companies listed on the TSX Venture Exchange in each of five major industry sectors – mining, energy & energy services, clean technology & life sciences, diversified industries and technology – based on a ranking formula with equal weighting given to return on investment, market cap growth, trading volume and analyst coverage. All data was as of December 31, 2017. Radient was ranked #1 of the 10 companies to have qualified within the diversified industries sector.
  • The Company entered into a binding letter of intent with 1396730 Alberta Ltd, a company owned by the Amnor Group, to acquire a 100% interest in 1631807 Alberta Ltd. (the "JV Company"). The Amnor Group is controlled by Harry Kaura, a director of the Company. The JV Company owns the land and building that contains the 20,000 square feet manufacturing facility in Edmonton, Canada operated by Radient. Pursuant to this transaction, Radient will be issuing 1,246,449 Common Shares to 1396730 Alberta Ltd. as consideration for a 100% ownership in the JV Company. This transaction remains subject to certain customary closing conditions, including (i) the satisfactory completion of due diligence by Radient; (ii) the execution of definitive documentation; and (iii) the approval of the transaction by the TSX Venture Exchange.

Denis Taschuk, President and CEO of Radient commented, “During Q3 we have seen substantial developments that have strengthened Radient’s position as a market leader in extraction solutions for the cannabis industry. The signing of Master Services Agreements with established private and public Canadian-Licensed Producers of cannabis will provide Radient with near-term revenues as we continue to execute long-term strategies, such as the expansion of our business operations in Europe, and the current expansion of our Edmonton manufacturing facility, which we expect to be completed in mid-calendar 2018.”

About Radient

Radient extracts natural compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000-square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and cannabis markets. Visit www.radientinc.com for more information.

In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle. Equities has been compensated with cash, common shares and/or warrants for market awareness services provided.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
RTI:CA Radient Technologies Inc. 1.07 -0.02 -1.83 177,814

Comments

Emerging Growth

Radient Technologies Inc.

Radient Technologies Inc is engaged in research, development and commercialization of environmentally responsible technology for the extraction, isolation and purification of soluble products from a wide range of materials using…

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Voleo

Voleo is a free download that allows you to form investment clubs with your friends, family, colleagues, classmates, teammates…basically anyone you know and trust. Invest and manage a stock portfolio…